Sulfonylurea and insulin administrations were not significantly associated with falls, possibly because intensive inpatient education and optimization of diabetes management, including the introduction of continuous glucose monitoring for patients receiving insulin therapy, effectively reduced the risk of hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.